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FIGURE 1. Late (1-year) mortality among patients randomized to off-pump coronary artery bypass grafting without cardiopulmonary bypass (OPCAB)
versus conventional coronary artery bypass grafting with cardiopulmonary bypass (ONCAB). BBS, Best Bypass Surgery trial; BHACAS, Beating Heart
Against Cardioplegic Arrest Study; CI, confidence interval;MASS, Medicine, Angioplasty, or Surgery Study;M-H, Mantel–Haenszel; PROMISS, Prospec-
tive Randomized Comparison of Off-Pump and On-Pump Multi-vessel Coronary Artery Bypass Surgery trial; ROOBY, Randomized On/Off Bypass trial;
SMART, Surgical Management of Arterial Revascularization Therapies trial; df, degrees of freedom.
Letters to the Editorbecause late mortality reduction
must imply the greatest clinical ben-
efit among patients undergoing coro-
nary artery bypass grafting.
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We read with interest the letter by
Takagi and colleagues, who suggest
that coronary artery bypass graft sur-
gery without cardiopulmonary bypass
(OPCAB) is associated with adverse
long-term outcomes based on a recent
systematic review they1 have per-
formed and recommend that the pre-
ferred technique for non–high-risk
patients should be coronary artery by-
pass graft surgery with cardiopulmo-
nary bypass (ONCAB).
We, however, question the validity
of their systematic review, which in-
cluded 11 randomized controlled
trials (RCTs) evaluating long-term
outcomes in more than 4000 low-risk
patients for the following reasons.
First, 7 of the 11 RCTs (please see ref-
erences E1-E7) included in the meta-
analysis carry moderate to high risk
of bias according to the Cochrane sys-
tem for the evaluation of the methodo-
logic quality of studies. Removal ofof Thoracic and Cardiovascular Surgerthese studies reveals comparable
mortality rates (risk ratio, 1.276;
95% confidence intervals, 0.858–
1.898; P ¼ .229) between OPCAB
and ONCAB surgery. Second, the
meta-analysis is heavily weighted by
the Randomized On/Off Bypass
(ROOBY) trial, which we have al-
ready critically analyzed and have
shown to have several flaws. Removal
of this trial from the meta-analysis
demonstrates no difference between
the 2 surgical techniques (odds ratio,
1.344; 95% confidence intervals,
0.952–1.896).1
Conversely and more fundamen-
tally, though, if we consider the find-
ings of Takagi and colleagues to be
robust, we may conclude that OPCAB
is not for all surgeons and patients.
Numerous observational studies from
centers specializing in OPCAB dem-
onstrate trends toward or significant
reductions in mortality in all groups
of patients.2-5 OPCAB surgeons
achieved anastomotic numbers
comparable with ONCAB surgeons
in these studies,4 and this is in contrast
to RCTs performed to date. Results of
the CRISP trial (Coronary artery
grafting in high RISk patients rando-
mised to off Pump or on pumpy c Volume 141, Number 5 1331
Letters to the Editorsurgery) (ISRCTN 29161170), which
is randomizing high-risk patients
(EuroSCORE>5) to either an expert
OPCAB or ONCAB surgeon, are
therefore eagerly awaited.
Until then, the current available
best evidence demonstrates that OP-
CAB is a safe alternative to ONCAB
with similar short- and long-term out-
comes in low-risk patients.
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To the Editor:
Dr Shields, instantly recognizable
throughout the world for his definitive
7 editions of the textbook General
Thoracic Surgery,1-7 died October 7,
2010, at the age of 88. He was born
in 1922 in Ambridge, Pennsylvania.
He attended Kenyon College in
Gambier, Ohio, graduating in 1943.
He graduated from Temple Medical
School in Philadelphia in 1947. His
earliest career interest was in cancer,
and he spent a year in the cancer
ward of Deaconess (now Beth Israel
Deaconess) Hospital in Boston. It
was in Boston where he met his
wife, Ann, of 62 years. He moved to
Northwestern University to complete
his training and was a Kanavel
research fellow in 1951. After
serving in the Korean War, he joined
the staff of the Lakeside Research
Veterans Administration Hospital,
where he became Chief of Surgery
and Professor of Surgery at
Northwestern University.
He was one of the few pioneering
surgeons who from the beginning of
his career through the newmillennium
focused on noncardiac thoracic sur-
gery. His academic investigations cen-
tered on lung cancer and its lymphatic
drainage. He taught many generations
of students and residents in surgery,
emphasizing precision in communica-
tion and economy of practice. He
taught and advocated the use of pul-
monary segmentectomy, whenever
possible.
Dr Shields was a prolific writer,
serving as an editor of Surgery, Gyne-
cology and Obstetrics, the forerunner
of the Journal of the American Col-Cardiovascular Surgery c May 2011lege of Surgeons, and as a member
of the editorial board of the Annals
of Thoracic Surgery. He edited several
books, including Mediastinal Sur-
gery8 and Bronchial Carcinoma,9 but
his most popular was General Tho-
racic Surgery. He espoused the con-
cept of global academic development
in thoracic surgery and always at-
tempted to give as many thoracic sur-
geons as possible, both from the
United States and from abroad, a voice
in his books. After retirement, he con-
tinued to lecture around the world. As
evidenced by his election to Phi Beta
Kappa, Alpha Omega Alpha, and
SigmaXi, hewas a scholar. To thoracic
surgeons everywhere, hewas a staunch
advocate for evidence-based practice
and journalistic integrity.
Joseph LoCicero III, MD
Emeritus Professor of Surgery SUNY
Downstate
Mobile, Ala
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